Vectors
Research from France and Sweden in vectors provides new insights
Published in Gene Therapy Weekly, October 19th, 2006
Study 1: A modified adenovirus vector that targets CD21 improved gene delivery to B lymphocytes.
According to a report from France, "Gene transfer by adenoviruses, which are widely used for gene therapy, may provide an alternative approach to treatment of several hematopoietic malignancies. However, a major limitation of adenovirus 5-based gene therapy lies in the natural tropism of the virus for the widely expressed hCAR receptor. The efficacy of adenoviral vectors could be improved if viral vectors that exhibit tissue-specific gene delivery were developed."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-10-19)
More Articles from Gene Therapy Weekly
- Cervical Cancer
Protein contributes to cervical tumorigenesis by regulating cyclin expression - Endocrinology
Biological properties of a chimeric gonadotropin clarified - Gene Research
Gene transfer to bladder smooth muscle achieved after bladder outlet obstruction - Gene Research
Steroidogenesis mediated by Cox protein in Leydig cells - Proteomics
Dopamine receptor inactivation alters expression of protein regulator - Angiology
Inhibition of thrombin generation is reversed by a recombinant factor - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
